INTERNATIONAL PATENT: GUANGZHOU PENGXING MEDICAL TECHNOLOGY CO., LTD., 广州鹏兴医药科技有限公司 FILES APPLICATION FOR "USE OF RAPAMYCIN COMBINED WITH PD-1 MONOCLONAL ANTIBODY IN PREPARATION OF DRUGS FOR TREATING COLORECTAL CANCER"

GENEVA, March 8 -- GUANGZHOU PENGXING MEDICAL TECHNOLOGY CO., LTD. (Room 506, No. 144 Huangsha Avenue, Liwan DistrictGuangzhou, Guangdong 510145), 广州鹏兴医药科技有限公司 (中国广东省广州市荔湾区黄沙大道144号506室) filed a patent application (PCT/CN2023/143213) for "USE OF RAPAMYCIN COMBINED WITH PD-1 MONOCLONAL ANTIBODY IN PREPARATION OF DRUGS FOR TREATING COLORECTAL CANCER" on Dec 29, 2023. With publication no. WO/2025/044015, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the Internati...